Sign up to save your podcasts
Or
Share Discontinuation of Tyrosine Kinase Inhibitors for Patients With Chronic Myeloid Leukemia
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Discontinuation of Tyrosine Kinase Inhibitors for Patients With Chronic Myeloid Leukemia
Interview with Ehab Atallah, MD, author of Assessment of Outcomes After Stopping Tyrosine Kinase Inhibitors Among Patients With Chronic Myeloid Leukemia: A Nonrandomized Clinical Trial
View all episodes
By JAMA Network
3.8
1111 ratings
Interview with Ehab Atallah, MD, author of Assessment of Outcomes After Stopping Tyrosine Kinase Inhibitors Among Patients With Chronic Myeloid Leukemia: A Nonrandomized Clinical Trial
More shows like JAMA Oncology Author Interviews
View all
NEJM This Week
320 Listeners
JAMA Clinical Reviews
496 Listeners
Journal of Clinical Oncology (JCO) Podcast
40 Listeners
JAMA Author Interviews
163 Listeners
ASCO Daily News
57 Listeners
The Daily
112,574 Listeners
JAMA Pediatrics Editors' Summary
38 Listeners
Up First from NPR
56,419 Listeners
JAMA Psychiatry Author Interviews
21 Listeners
JAMA Neurology Author Interviews
12 Listeners
JAMA Cardiology Author Interviews
8 Listeners
JAMA Dermatology Author Interviews
16 Listeners
JAMA Internal Medicine Author Interviews
18 Listeners
JAMA Ophthalmology Author Interviews
5 Listeners
JAMA Otolaryngology–Head Neck Surgery Author Interviews
6 Listeners
ASCO Guidelines
44 Listeners
JAMAevidence The Rational Clinical Examination
29 Listeners
JAMA Pediatrics Author Interviews
9 Listeners
JAMA Medical News
90 Listeners
JAMAevidence Users' Guides to the Medical Literature
14 Listeners
JAMAevidence Care at the Close of Life
5 Listeners
JAMA Network Open Conversations
5 Listeners
Coronavirus (COVID-19) Q
106 Listeners
JAMAevidence JAMA Guide to Statistics and Methods
19 Listeners
The Rest Is History
14,605 Listeners
JAMA Health Forum Conversations
3 Listeners
Bad Rap: The Case Against Diddy
1,227 Listeners